background
threaten
quickli
overwhelm
exist
critic
care
infrastructur
usa
system
tissu
plasminogen
activ
tpa
previous
demonstr
improv
pao
fio
mmhg
given
critic
ill
patient
acut
respiratori
distress
syndrom
ard
unclear
extent
tpa
may
impact
populationbas
surviv
current
us
pandem
method
decis
analyt
markov
state
transit
model
creat
simul
life
critic
ill
patient
transit
either
recoveri
death
two
patient
group
simul
patient
group
patient
receiv
tpa
immedi
upon
diagnosi
ard
patient
receiv
standard
therapi
ard
base
case
critic
ill
patient
defin
refractori
pao
fio
mmhg
salvag
use
criteria
transit
sever
moder
mild
ard
recoveri
death
estim
markov
model
paramet
extract
exist
literatur
result
use
tpa
associ
reduc
mortal
ttpa
vs
tpa
base
case
patient
extrapol
project
elig
salvag
use
tpa
usa
peak
mortal
patient
reduc
optim
social
distanc
tpa
vs
tpa
social
distanc
tpa
vs
tpa
scenario
conclus
salvag
use
tpa
may
improv
recoveri
ard
patient
therebi
reduc
mortal
ensur
suffici
resourc
manag
pandem
pandem
quickli
spread
throughout
world
threaten
overwhelm
critic
care
bed
suppli
usa
upcom
week
march
case
confirm
case
expand
exponenti
rate
patient
past
h
death
estim
final
death
toll
appropri
social
distanc
measur
fail
rang
usa
dire
project
requir
urgent
thought
creativ
action
amongst
clinician
salvag
use
therapeut
target
attenu
acut
respiratori
distress
syndrom
ard
sequala
mortal
high
interest
promis
therapeut
may
invalu
mitig
larg
burden
advanc
diseas
phase
clinic
trial
salvag
use
ard
report
signific
improv
pao
fio
system
tissu
plasminogen
activ
tpa
given
patient
sever
ard
mechan
find
theoriz
involv
dissolut
extens
fibrin
burden
microcircul
airway
space
ard
grow
evid
lethal
ard
associ
dissemin
intravascular
fibrin
deposit
consequ
reviv
interest
explor
role
tpa
reduc
ardsrel
mortal
patient
elig
salvag
use
therapeut
multicent
group
usa
propos
tpa
could
invalu
tool
reduc
sever
ard
relat
act
salvag
techniqu
rescu
patient
mechan
ventil
avail
investig
cohort
set
forward
treatment
plan
impend
crisi
howev
remain
unclear
extent
potenti
pao
fio
improv
tpa
would
reduc
icu
bed
requir
populationbas
mortal
crisi
longterm
random
clinic
trial
practic
midst
current
pandem
howev
unpreced
set
decis
analyt
markov
model
may
offer
guidanc
markov
model
use
exist
publish
data
project
movement
patient
simul
health
state
time
markov
model
previous
use
group
increasingli
appli
model
healthcar
challeng
trial
data
may
lack
forese
futur
markov
model
creat
estim
impact
salvag
use
system
tpa
patient
addit
aggress
use
intervent
earlier
state
diseas
progress
decis
analyt
markov
state
transit
model
creat
simul
life
critic
ill
transit
either
recoveri
death
two
patient
group
simul
follow
patient
receiv
tpa
immedi
upon
diagnosi
ard
patient
receiv
standard
therapi
ard
medic
decisionmak
softwar
util
creation
comput
model
data
treeag
softwar
inc
williamstown
base
case
patient
defin
pao
fio
pf
mmhg
approxim
initi
within
day
pao
fio
current
patient
would
elig
salvag
use
therapeut
decis
model
structur
fig
one
hundr
thousand
patient
model
two
arm
decis
model
patient
arm
model
began
follow
admiss
simul
patient
icu
patient
tpa
arm
receiv
therapi
within
day
admiss
patient
tpa
receiv
standard
ard
treatment
patient
follow
transit
severemoderatemild
ard
recoveri
death
sevenday
cycl
length
use
patient
die
recov
state
transit
probabl
tabl
transit
probabl
extract
exist
publish
literatur
use
medlin
electron
search
previous
describ
naughler
et
al
transit
probabl
variou
time
period
convert
rate
per
cycl
actuari
method
cycl
probabl
seven
day
transit
probabl
exp
p
probabl
event
exp
base
natur
logarithm
r
rate
event
occur
time
period
day
ln
natur
logarithm
natur
histori
ard
extract
bellani
et
al
estim
improv
pao
fio
follow
tpa
result
hardaway
et
al
appli
assum
patient
respons
tpa
follow
normal
distribut
regard
probabl
transit
sever
moder
mild
ard
standard
score
calcul
use
z
standard
score
x
pao
fio
cutoff
valu
mmhg
mmhg
mean
pao
fio
follow
treatment
standard
deviat
standard
score
convert
percentil
use
tabl
onesid
standard
normal
distribut
calcul
transit
probabl
assum
independ
initi
ard
class
mortal
rate
follow
system
tpa
extrapol
gustoi
trial
wherebi
tpa
use
associ
death
nonfat
debilit
stroke
rate
group
previous
use
present
approach
transit
probabl
creation
markov
decis
analysi
estim
impact
weight
loss
intervent
renal
liver
transplant
candid
imperi
colleg
recent
publish
project
critic
care
bed
util
variou
scenario
social
distanc
optim
social
distanc
impact
tpa
mortal
extrapol
standard
method
upon
project
creat
populationbas
mortal
estim
two
scenario
model
follow
tpa
given
patient
elig
salvag
use
therapeut
patient
present
icu
ard
estim
model
extract
wuhan
experi
patient
follow
cycl
model
fig
b
base
case
patient
patient
began
sever
salvag
use
ard
health
state
transit
ard
health
state
mild
moder
sever
either
recoveri
death
compar
patient
undergo
tpa
treatment
patient
receiv
salvag
use
tpa
therapi
transit
recoveri
floor
statusdischarg
quickli
frequent
correspondingli
use
tpa
associ
reduc
mortal
ttpa
vs
tpa
conclus
model
death
nonfat
disabl
stroke
follow
system
tpa
gustoi
trial
sensit
analysi
initi
within
day
ard
statu
mild
vs
moder
vs
salvag
use
criteria
ard
perform
fig
util
tpa
estim
significantli
reduc
mortal
initi
mild
result
base
case
extrapol
imperi
colleg
respons
team
project
tempor
diseas
burden
util
salvag
use
scenario
peak
mortal
patient
reduc
optim
social
distanc
tpa
vs
tpa
social
distanc
fig
current
interest
util
tpa
ard
patient
repres
novel
potenti
therapi
reduc
mortal
current
pandem
markov
model
salvag
use
estim
minim
impact
surviv
howev
aggress
use
tpa
stage
ard
estim
significantli
improv
ventilatori
requir
patient
therebi
improv
surviv
furthermor
patient
requir
critic
care
bed
reduc
amount
time
compar
current
estim
util
standard
method
ard
treatment
model
offer
hope
support
global
grow
number
center
consid
salvag
use
system
tpa
markov
model
reli
extrapol
sever
weak
model
address
although
hardaway
et
al
demonstr
improv
pf
ratio
tpa
administr
patient
sever
ard
pf
clear
whether
effect
would
sustain
patient
tpa
would
theoret
reduc
sequala
ard
lead
improv
viral
clearanc
longterm
efficaci
proven
current
time
addit
model
base
data
wuhan
experi
popul
whose
demograph
approach
ident
usa
furthermor
tpa
arm
transit
probabl
ard
progressimprov
associ
mortal
assum
mirror
diseasesan
assumpt
insuffici
data
exist
valid
despit
limit
markov
model
realiti
imped
global
disast
come
true
prior
model
overwhelm
exponenti
growth
diseas
itali
satur
medic
system
almost
nightmarishli
exceed
expect
itali
mortal
rate
overal
death
china
protocol
salvag
use
system
tpa
plan
sever
center
usa
salvag
use
efficaci
improv
pulmonari
function
ard
relat
quick
respons
implement
clinic
trial
would
necessari
gener
suffici
evid
valid
treatment
effect
reduc
ardsrel
mortal
rate
growth
pandem
time
enemi
without
effect
social
implement
curtail
rapid
spread
viru
tpa
may
never
opportun
use
beyond
salvag
use
abbrevi
tpa
tissu
plasminogen
activ
ard
acut
respiratori
distress
syndrom
pf
ratio
partial
pressur
blood
oxygen
level
percent
oxygen
inhal
